Tick Bites Statistics in US 2026 | Treatments, Season & Key Facts

Tick Bites in the United States 2026

Tick bites statistics in US point to one of the most active tick seasons in nearly a decade. The CDC reported that emergency room visits for tick bites rose more than 25% in April 2026 compared with April 2025, marking the highest April total since 2017. Every year, an estimated 31 million people across the United States are bitten by a tick, and public health experts at a Johns Hopkins Bloomberg School of Public Health briefing on 5 May 2026 warned this spring’s early surge could signal a particularly severe season for Lyme disease and other tick-borne illnesses.

This article compiles verified tick bites statistics in US 2026 from the CDC, Johns Hopkins Bloomberg School of Public Health, and peer-reviewed medical research. It covers how many people are affected, which diseases ticks transmit, where cases are concentrated geographically, current treatment protocols, the length of tick season, and the latest developments in vaccine research, giving a complete, data-backed picture of the tick-borne disease landscape in America this year.

Interesting Facts About Tick Bites in US 2026

Source: CDC; Johns Hopkins Bloomberg School of Public Health, 2026

As a tick bites statistics in US 2026 starting point, these numbers confirm a season that arrived earlier and harder than usual. With 31 million Americans bitten annually and ER visits already up over 25% by April, researchers describe this year’s early data as a warning sign rather than a one-off spike. The gap between the officially reported 89,000 Lyme disease cases in 2023 and the researcher-estimated 500,000 actual annual cases highlights a well-documented underreporting problem, particularly in areas where tick-borne illness is newly emerging or historically considered rare.

Timing matters enormously for tick bite safety. Because it typically takes 24 to 48 hours of attachment for an infected tick to transmit the bacteria that causes Lyme disease, prompt tick checks and removal remain one of the single most effective prevention tools available. With 90% of US Lyme cases concentrated in the Northeast, Mid-Atlantic, and Upper Midwest, and a typical tick season running from April through November, regional awareness and seasonal timing are just as important as knowing the raw national numbers.

Lyme Disease Case Statistics in US 2026

Source: CDC Lyme Disease Surveillance and Data; Associated Press; Vax-Before-Travel, 2026

Lyme disease remains the most common tick-borne illness in the United States, and 2026 data shows both the scale and the regional intensity of the problem. While CDC’s official surveillance system recorded over 89,000 confirmed cases in 2023, researchers using clinical treatment data and insurance claims estimate the real annual burden sits closer to 500,000 cases, since not every diagnosis is formally reported through the National Notifiable Diseases Surveillance System. In the Northeast, peak-season emergency department visits for tick bites reach as high as 283 per 100,000 total ED visits, reflecting just how concentrated the burden is in certain states.

Early 2026 surveillance data from Connecticut — the state that gave Lyme disease its name — illustrates the intensity of this year’s season, with roughly 30 ticks submitted for testing daily and 40% testing positive for the Lyme-causing bacteria. CDC epidemiologist Alison Hinckley noted that ticks are already active and biting well ahead of the traditional May peak, a signal experts say reflects both milder winters and expanding tick habitats tied to longer-term climate patterns.

Other Major Tick-Borne Diseases in US 2026

Source: CDC; The Wellness Company; Medscape Rocky Mountain Spotted Fever Guidelines, 2026

While Lyme disease dominates headlines, 2026 data shows several other tick-borne diseases carry far higher fatality risk if treatment is delayed. Rocky Mountain spotted fever, spread primarily by the American dog tick and brown dog tick, is concentrated in an unexpected cluster of states — North Carolina, Tennessee, Missouri, Arkansas, and Oklahoma — which together account for over 60% of all US cases, despite the disease’s western-sounding name. Starting doxycycline within the first five days of symptoms reduces the fatality rate from around 20% down to approximately 5%, making early treatment far more important than laboratory confirmation, which can take days.

Alpha-gal syndrome, a potentially life-threatening allergic condition triggered specifically by lone star tick bites, sensitizes the immune system to a carbohydrate found in beef, pork, lamb, dairy, and even some medications. Cases cluster heavily in Virginia, Kentucky, Arkansas, Missouri, and Tennessee, though 2026 surveillance shows a growing number of reports emerging in New York and New England, consistent with the broader pattern of tick habitat expansion now being documented nationwide.

Tick Bite Treatment Statistics in US 2026

Source: CDC Clinical Care Guidelines; Medscape; Stony Brook Medicine, 2026

Doxycycline remains the single most important drug in tick-borne disease treatment, effective against Lyme disease, Rocky Mountain spotted fever, anaplasmosis, and ehrlichiosis alike. CDC clinical guidance stresses that doxycycline should be started immediately in suspected RMSF cases without waiting for laboratory confirmation, since the characteristic rash may not appear until day six of illness, by which point delayed treatment substantially raises the risk of severe complications or death. The drug is considered safe for children of all ages, including those under eight, and for pregnant patients, reversing older guidance that once limited its pediatric use.

For Lyme disease specifically, a standard two-to-four-week course of oral doxycycline successfully treats the large majority of early-stage cases, while later-stage infections — often the result of delayed diagnosis — may require intravenous antibiotics and can involve lasting joint damage, neurological symptoms, or heart rhythm disturbances. Removing an attached tick within 24 hours remains the most effective non-pharmaceutical intervention, since the Lyme bacteria generally requires 24 to 48 hours of attachment to transmit, giving prompt, correct removal genuine protective value even after a bite has already occurred.

Tick Season and Geographic Distribution Statistics in US 2026

Source: Johns Hopkins Bloomberg School of Public Health; Katie Couric Media/CDC, 2026

Tick season in most parts of the United States runs from April through November, tracking closely with temperatures above freezing, though ticks can remain active year-round in regions where hard freezes are rare. Johns Hopkins researchers speaking at the May 2026 media briefing identified three primary ecological drivers behind this year’s early surge: milder winters allowing more ticks to survive into the following season, growing deer populations providing abundant hosts for adult ticks, and continued suburban development pushing more people into direct contact with wooded and brushy habitat.

While the Northeast, Midwest, and Southeast remain the top three regions for raw tick bite volume, researchers specifically flagged the South as an area of growing concern, noting that tick populations are expanding into regions where residents and even some healthcare providers are less accustomed to recognizing tick-borne disease symptoms. This geographic spread is part of why updated CDC case data for 2024 is expected to show continued growth when published later in 2026, extending a multi-decade pattern of Lyme disease’s documented range expansion since 1995.

Prevention and Vaccine Development Statistics in US 2026

Source: Pfizer; Valneva SE; Vax-Before-Travel, March 2026

No FDA-approved Lyme disease vaccine currently exists for the general public, following the discontinuation of the original LYMErix vaccine back in 2002. That gap may finally close in the coming years: on 23 March 2026, Pfizer and Valneva SE announced positive topline results from their Phase 3 VALOR trial of vaccine candidate PF-07307405, a six-valent OspA-based vaccine that demonstrated approximately 73% efficacy in preventing confirmed Lyme disease cases among trial participants aged five and older.

Until a vaccine reaches full approval, CDC prevention guidance remains centered on practical, low-cost measures: wearing EPA-registered insect repellent and permethrin-treated clothing, performing thorough tick checks after outdoor activity, and removing any attached tick as quickly as possible using fine-tipped tweezers, grasping close to the skin and pulling straight upward. Standard Lyme disease testing is covered by most insurance plans, and generic doxycycline remains inexpensive and widely available, while uninsured patients can access both evaluation and treatment through federally qualified health centers and many urgent care clinics nationwide.

Emergency Room and Healthcare Utilization Statistics in US 2026

Source: CDC National Syndromic Surveillance Program; Medscape; MedicalDaily, 2026

The CDC’s tick bite tracking relies on its National Syndromic Surveillance Program, which monitors emergency department visit data in near real time — a system that flagged this year’s 25%+ increase in April 2026 well before annual Lyme disease case counts could be finalized. Importantly, this ER-based tracking tool does not capture visits to urgent care clinics or primary care physicians, meaning the true scale of this year’s tick bite surge is likely even larger than the emergency department data alone suggests.

Healthcare utilization patterns also vary significantly by disease severity. While most Lyme disease cases can be managed successfully in an outpatient setting with oral doxycycline, roughly 10% of outpatients initially treated for Rocky Mountain spotted fever ultimately require hospital admission, underscoring why CDC guidance urges close follow-up rather than a single initial visit for anyone with a confirmed or suspected tick-borne illness. For patients without immediate access to in-person care, telehealth consultations are considered a reasonable option for initial evaluation, provided the case does not involve symptoms requiring a physical examination, such as an active rash needing direct visual assessment.

Long-Term Health Impact Statistics in US 2026

Source: CDC Lyme Disease Surveillance and Data; peer-reviewed RMSF outcomes research, 2026

The long-term health consequences of delayed tick-borne disease treatment extend well beyond the initial illness. Late-stage Lyme disease, typically the result of a missed or delayed diagnosis, can produce joint damage, neurological complications, and heart rhythm disturbances that persist for months to years even after a full course of antibiotics has been completed. Peer-reviewed research on Rocky Mountain spotted fever outcomes similarly shows that among survivors whose treatment was delayed, up to 16% experience life-altering sequelae, including amputations and permanent neurologic deficits — a stark illustration of why early recognition and prompt doxycycline treatment carry such outsized importance for long-term patient outcomes.

Interpreting long-term national trend data also requires care, since the CDC’s official case definition for Lyme disease has been revised five separate times since surveillance began in 1991 — in 1996, 2008, 2011, 2017, and most recently 2022. Each revision changed how cases are classified and counted, meaning direct year-over-year comparisons across different definition periods can understate or overstate the disease’s true growth. Across all 35 years of national surveillance, however, the overall geographic and case-count trend has moved in one consistent direction: outward and upward, reinforcing why 2026’s early-season ER data is being treated as a meaningful warning sign rather than a statistical anomaly.

Tick Removal and At-Home Safety Statistics in US 2026

Source: CDC; Cleveland Clinic; Associated Press, 2026

Correct tick removal technique significantly affects infection risk, which is why CDC and clinical guidance are highly specific on the process: use fine-tipped tweezers to grasp the tick as close to the skin’s surface as possible, then pull upward with steady, even pressure rather than twisting or jerking, which can leave mouthparts embedded in the skin. After removal, cleaning the bite site with soap and water and monitoring for fever, rash, or severe headache over the following two weeks rounds out the recommended at-home protocol, with prompt medical attention advised the moment any of those symptoms appear.

On prevention, EPA-registered repellents containing DEET, picaridin, or permethrin remain the most effective chemical defenses, with picaridin-based products generally considered a safe option for both children and pregnant individuals according to clinical guidance. Simple behavioral choices matter too: wearing long sleeves and pants tucked into socks while in wooded or grassy areas, and staying centered on hiking trails rather than brushing against tall grass at the trail’s edge, both meaningfully reduce the chances of picking up a tick in the first place — protecting not just the hiker, but any pets accompanying them as well.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE